Shingles (Herpes Zoster): Symptoms, Treatment, and Prevention with Vaccination

What Is Shingles?

Shingles is reactivation of the varicella-zoster virus (VZV), which remains dormant in dorsal root ganglia after chickenpox. It typically affects one dermatome, causing a painful vesicular rash.

Symptoms

Prodrome (1–5 days before rash)

  • Burning, tingling, itching, or deep pain in a unilateral dermatomal distribution.
  • Fever, headache, malaise, photophobia.

Active Rash

  • Erythematous base with clustered vesicles → pustules → crusts over 7–10 days.
  • Thoracic (50%), cervical, ophthalmic (V1), and lumbar dermatomes most common.
  • Rash does not cross the midline.

Complications

  • Postherpetic neuralgia (PHN): Pain persisting >90 days after rash onset; risk increases with age (>50% if >80).
  • Herpes zoster ophthalmicus: keratitis, uveitis, vision loss.
  • Ramsay Hunt syndrome (facial nerve + ear rash).
  • Bacterial superinfection, motor neuropathy, encephalitis (rare).

Treatment

Antivirals (start within 72 hours of rash onset)

  • Valacyclovir 1 g TID × 7 days (preferred)
  • Famciclovir 500 mg TID × 7 days
  • Acyclovir 800 mg 5×/day × 7 days (less bioavailable)

Adjunctive Therapies

  • Corticosteroids (prednisone taper) may reduce acute pain but not PHN—use selectively.
  • Analgesics: NSAIDs, gabapentinoids, topical lidocaine, opioids if severe.

Prevention: Vaccination

  • Shingrix (RZV): Recombinant subunit vaccine, 2 doses 2–6 months apart. >90% efficacy; recommended for immunocompetent adults ≥50 and immunocompromised ≥19.
  • Zostavax (live attenuated) no longer used in the US.

Key Points

  • Shingles is not contagious as shingles, but VZV from lesions can cause chickenpox in non-immune contacts.
  • Early antiviral therapy shortens duration and reduces PHN risk.
  • Vaccination is the most effective prevention.

Sprains - Related Articles